title: National Action Plan for Adverse Drug Event Prevention: Recommendations for Safer Outpatient Opioid Use.
abstract: Adverse drug events (ADEs) have been highlighted as a major patient safety and public health challenge by the National Action Plan for Adverse Drug Event Prevention (ADE Action Plan), which was released by the Office of Disease Prevention and Health Promotion (ODPHP) in August 2014. The ADE Action Plan focuses on surveillance, evidence-based prevention, incentives, and oversights, additional research needs as well as possible measures and metrics to track progress of ADE prevention within three drug classes: anticoagulants, diabetes agents, and opioids.Objectives and Recommendations. With outpatient opioid prescriptions being a great concern among many healthcare providers, this article focuses on recommendations from the ADE Action Plan to help guide safer opioid use in healthcare delivery settings. Its aim is to discuss current federal methods in place to prevent opioid ADEs while also providing evidence to encourage providers and hospitals to innovate new systems and practices to increase prevention.
authors.affiliation: *Previously with Office of Disease Prevention and Health Promotion (ODPHP), US Department of Health and Human Services, Washington, DC; Currently with MedStar Georgetown University Hospital, Department of Radiology, Washington, DC.
authors.forename: Aaron R
authors.initials: AR
authors.lastname: Ducoffe
authors.affiliation: Previously with ODPHP, Washington, DC; Currently with Centers for Medicare & Medicaid Services, Baltimore, Maryland.
authors.forename: Andrew
authors.initials: A
authors.lastname: York
authors.affiliation: Previously with ODPHP, Washington, DC; Currently with National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
authors.forename: Dale J
authors.initials: DJ
authors.lastname: Hu
authors.affiliation: Agency for Healthcare Research and Quality, Rockville, Maryland.
authors.forename: Deborah
authors.initials: D
authors.lastname: Perfetto
authors.affiliation: Previously with the Pain Research, Informatics, Multi-Morbidities and Education (PRIME) Center, Virginia Connecticut Healthcare System, West Haven, Connecticut; Currently with Yale University, New Haven, Connecticut, USA robert.kerns@va.gov.
authors.forename: Robert D
authors.initials: RD
authors.lastname: Kerns
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control*; D006287:Health Planning Guidelines; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D009293:Opioid-Related Disorders / Q000517:prevention & control*
chemical_list: D000701:Analgesics, Opioid
keywords: Adverse Drug Events; Opioids; Pain Management; Quality of Healthcare